Tumor-to-dendritic cell reprogramming induces immunogenic lymphoid structures across cancers.
Ascic E, Chatelain C, Fontanari G, Perez Bucio C, Zhang L, Thrasyvoulou M, Karali V, Ballocci T, de Rosa Torres M, Rabreau S, Hampton K, Lauss M, Phung B, Akerstrom F, Sundaramurthy AK, Catena X, Fan C, Jonathan S, Darabi A, Bengzon J, Rosa FF, Jonsson GB, Kurochkin I, Pereira CF
Immunity. 2026 Nov 4:S1074-7613(26)00432-2. doi: 10.1016/j.immuni.2026.10.006.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 261252 | pLenti-pSFFV-Cd40-Puro | Lentiviral vector for overexpression of mouse Cd40 |
| 261253 | pLenti-pSFFV-Ifnb-Puro | Lentiviral vector for overexpression of mouse Ifnb |
| 261255 | pLenti-pSFFV-Lta-Puro | Lentiviral vector for overexpression of mouse Lta |
| 261256 | pLenti-pSFFV-Tnfa-Puro | Lentiviral vector for overexpression of mouse Tnfa |
| 261259 | pLV CIITA-hUbC-Cas9-T2A-GFP | Lentiviral CRISPR/Cas9 vector for knockout of mouse Ciita, co-expressing a GFP reporter. |